Resting state connectivity studies link ketamine’s antidepressant effects with normalisation of the brain connectivity changes that are observed in depression. These changes, however, usually co-occur with improvement in depressive symptoms, making it difficult to attribute these changes to ketamine’s effects per se.
Aims:
Our aim is to examine the effects of ketamine in brain connectivity, 2 h after its administration in a cohort of volunteers with remitted depression. Any significant changes observed in this study could provide insight of ketamine’s antidepressant mechanism as they are not accompanied by symptom changes.
Methods:
In total, 35 participants with remitted depression (21 females, mean age = 28.5 years) participated in a double-blind, placebo-controlled study of ketamine (0.5 mg/kg) or saline. Resting state scans were acquired approximately 2 h after the ketamine infusion. Brain connectivity was examined using a seed-based approach (ventral striatum, amygdala, hippocampus, posterior cingulate cortex and subgenual anterior cingulate cortex (sgACC)) and a brain network analysis (independent component analysis).
Results:
Decreased connectivity between the sgACC and the amygdala was observed approximately 2 h after the ketamine infusion, compared to placebo (pFWE < 0.05). The executive network presented with altered connectivity with different cortical and subcortical regions. Within the network, the left hippocampus and right amygdala had decreased connectivity (pFWE < 0.05).
Conclusions:
Our findings support a model whereby ketamine would change the connectivity of brain areas and networks that are important for cognitive processing and emotional regulation. These changes could also be an indirect indicator of the plasticity changes induced by the drug.
AbdallahCGAhnK-HAverillLA, et al. (2021) A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants. Neuropsychopharmacology46: 478–485.
2.
AdmonRHolsenLMAizleyH, et al. (2015) Striatal hyper-sensitivity during stress in remitted individuals with recurrent depression. Biol Psychiat78: 67–76.
3.
AlexanderLJelenLAMehtaMA, et al. (2021) The anterior cingulate cortex as a key locus of ketamine’s antidepressant action. Neurosci Biobehav Rev127: 531–554.
4.
AndersonMJRobinsonJ (2001) Permutation tests for linear models. Austr NZ J Stat43: 75–88.
5.
Andrews-HannaJRReidlerJSSepulcreJ, et al. (2010) Functional-anatomic fractionation of the Brain’s default network. Neuron65: 550–562.
6.
AvantsBBTustisonNJSongG, et al. (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage54: 2033–2044.
7.
BeckmannCMackayCFilippiniN, et al. (2009) Group comparison of resting-state FMRI data using multi-subject ICA and dual regression. NeuroImage47: S148.
8.
BermanRMCappielloAAnandA, et al. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiat47: 351–354.
9.
ColloGPichE (2018) Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression. Neural Regen Res13: 645.
10.
ConnollyCGWuJHoTC, et al. (2013) Resting-state functional connectivity of subgenual anterior cingulate cortex in depressed adolescents. Biol Psychiat74: 898–907.
11.
DolcosFLaBarKSCabezaR (2005) Remembering one year later: Role of the amygdala and the medial temporal lobe memory system in retrieving emotional memories. Proc Natl Acad Sci102: 2626–2631.
12.
DrevetsWCSavitzJTrimbleM (2008) The subgenual anterior cingulate cortex in mood disorders. CNS Spect13: 663–681.
13.
DunlopKTalishinskyAListonC (2019) Intrinsic brain network biomarkers of antidepressant response: A review. Curr Psychiat Rep21: 87.
14.
EvansJWSzczepanikJBrutschéN, et al. (2018) Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration. Biol Psychiat84: 582–590.
15.
FarmerCAGilbertJRMoaddelR, et al. (2020) Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Neuropsychopharmacology45: 1398–1404.
16.
Foland-RossLCCooneyREJoormannJ, et al. (2014) Recalling happy memories in remitted depression: A neuroimaging investigation of the repair of sad mood. Cognit Affect Behav Neurosci14: 818–826.
17.
GabbayVElyBALiQ, et al. (2013) Striatum-based circuitry of adolescent depression and anhedonia. J Am Acad Child Adolesc Psychiat52: 628.e13–641.e13.
18.
GilbertJRZarateCA (2020) Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation. Pharmacol BiochemBehav189: 172856.
19.
GorwoodPCorrubleEFalissardB, et al. (2008) Toxic effects of depression on brain function: Impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry165: 731–739.
20.
Guerra-CarrilloBMackeyAPBungeSA (2014) Resting-state fMRI: A window into human brain plasticity. Neuroscientist20: 522–533.
21.
HakamataYMizukamiSIzawaS, et al. (2020) Basolateral amygdala connectivity with subgenual anterior cingulate cortex represents enhanced fear-related memory encoding in anxious humans. Biol Psychiat Cognit Neurosci Neuroimag5: 301–310.
22.
HlinkaJPalušMVejmelkaM, et al. (2011) Functional connectivity in resting-state fMRI: Is linear correlation sufficient?NeuroImage54: 2218–2225.
23.
JenkinsonMBannisterPBradyM, et al. (2002) Improved optimization for the Robust and accurate linear registration and motion correction of brain images. NeuroImage17: 825–841.
24.
KaiserRHAndrews-HannaJRWagerTD, et al. (2015) Large-scale network dysfunction in major depressive disorder: Meta-analysis of resting-state functional connectivity. JAMA Psychiat72: 603–611.
25.
KotoulaVStringarisAMackesN, et al. (2021a) Ketamine modulates the neural correlates of reward processing in unmedicated patients in remission from depression. Biol Psychiat Cognit Neurosci Neuroimag7: 285–292.
26.
KotoulaVWebsterTStoneJ, et al. (2021b) Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review. Brain Neurosci Adv5: 23982128211055424.
27.
LangnesESneveMHSedereviciusD, et al. (2020) Anterior and posterior hippocampus macro- and microstructure across the lifespan in relation to memory—A longitudinal study. Hippocampus30: 678–692.
28.
LeeW-CAHuangHFengG, et al. (2005) Dynamic remodeling of dendritic arbors in GABAergic interneurons of adult visual cortex. PLoS Biol4: e29.
29.
LevarNVan DoesumTJDenysD, et al. (2019) Anterior cingulate GABA and glutamate concentrations are associated with resting-state network connectivity. Sci Rep9: 2116.
30.
LutkenhoffESRosenbergMChiangJ, et al. (2014) Optimized brain extraction for pathological brains (optiBET). PLoS One9: e115551.
31.
MakrisNGoldsteinJMKennedyD, et al. (2006) Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res83: 155–171.
32.
MasonOJMorganCJMStefanovicA, et al. (2008) The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis. Schizophr Res103: 138–142.
33.
McCabeCCowenPJHarmerCJ (2009) Neural representation of reward in recovered depressed patients. Psychopharmacology205: 667–677.
34.
MenonB (2019) Towards a new model of understanding – The triple network, psychopathology and the structure of the mind. Med Hypotheses133: 109385.
35.
MkrtchianAEvansJWKrausC, et al. (2020) Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Mol Psychiat26: 3292–3301.
36.
MontgomeryAJMehtaMAGrasbyPM (2006) Is psychological stress in man associated with increased striatal dopamine levels?: A [11C]raclopride PET study. Synapse60: 124–131.
37.
NelsonEAKraguljacNVMaximoJO, et al. (2022) Hippocampal dysconnectivity and altered glutamatergic modulation of the default mode network: A combined resting-state connectivity and magnetic resonance spectroscopy study in schizophrenia. Biol Psychiat: Cognit Neurosci Neuroimag7: 108–118.
38.
NgTHAlloyLBSmithDV (2019) Meta-analysis of reward processing in major depressive disorder reveals distinct abnormalities within the reward circuit. Transl Psychiat9: 1–10.
39.
PruimRHRMennesMvan RooijD, et al. (2015) ICA-AROMA: A robust ICA-based strategy for removing motion artifacts from fMRI data. NeuroImage112: 267–277.
40.
RamasubbuRKonduruNCorteseF, et al. (2014) Reduced intrinsic connectivity of amygdala in adults with major depressive disorder. Front Psychiat5: 17.
41.
RiggsLMAracavaYZanosP, et al. (2020) (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism. Neuropsychopharmacology45: 426–436.
ScharnowskiFNicholsonAAPichonS, et al. (2020) The role of the subgenual anterior cingulate cortex in dorsomedial prefrontal–amygdala neural circuitry during positive-social emotion regulation. Human Brain Mapp41: 3100–3118.
44.
ShirayamaYHashimotoK (2018) Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: Comparison with (R)-ketamine. Int J Neuropsychopharmacol21: 84–88.
45.
SmithSMJenkinsonMWoolrichMW, et al. (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage23: S208–S219.
46.
SmithSMNicholsTE (2009) Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage44: 83–98.
47.
Stampanoni BassiMIezziEGilioL, et al. (2019) Synaptic plasticity shapes brain connectivity: Implications for network topology. Int J Mol Sci20: E6193.
48.
TangSLuLZhangL, et al. (2018) Abnormal amygdala resting-state functional connectivity in adults and adolescents with major depressive disorder: A comparative meta-analysis. EBioMed36: 436–445.
49.
VasavadaMMLoureiroJKubickiA, et al. (2021) Effects of serial ketamine infusions on corticolimbic functional connectivity in major depression. Biol Psychiat: Cognit Neurosci Neuroimag6: 735–744.
50.
WinklerAMRidgwayGRWebsterMA, et al. (2014) Permutation inference for the general linear model. NeuroImage92: 381–397.
51.
WoolrichMWRipleyBDBradyM, et al. (2001) Temporal autocorrelation in univariate linear modeling of FMRI data. NeuroImage14: 1370–1386.
52.
WuMMinkowiczSDumrongprechachanV, et al. (2021) Ketamine rapidly enhances glutamate-evoked dendritic spinogenesis in medial prefrontal cortex through dopaminergic mechanisms. Biol Psychiat89: 1096–1105.
53.
YanC-GChenXLiL, et al. (2019) Reduced default mode network functional connectivity in patients with recurrent major depressive disorder. Proc Natl Acad Sci116: 9078–9083.
54.
YoungKDSiegleGJBodurkaJ, et al. (2016) Amygdala activity during autobiographical memory recall in depressed and vulnerable individuals: Association with symptom severity and autobiographical overgenerality. Am J Psychiat173: 78–89.
55.
ZanosPGouldTD (2018) Mechanisms of ketamine action as an antidepressant. Mol Psychiat23: 801–811.
56.
ZanosPMoaddelRMorrisPJ, et al. (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature533: 481–486.
57.
ZarateCABrutscheNLajeG, et al. (2012) Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiat72: 331–338.
58.
ZarateCASinghJBCarlsonPJ, et al. (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiat63: 856–864.
59.
ZhaoXVenkataSLVMoaddelR, et al. (2012) Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression: PopPK model of ketamine and three major metabolites. Br J Clin Pharmacol74: 304–314.
60.
ZhengHXuLXieF, et al. (2015) The altered triple networks interaction in depression under resting state based on graph theory. BioMed Res Int2015: 386326.
